| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/26/2001 | CA2479511A1 Compositions and methods for the treatment of tumor |
| 07/26/2001 | CA2479498A1 Compositions and methods for the treatment of tumor |
| 07/26/2001 | CA2398842A1 Replication deficient adenovirus vectors |
| 07/26/2001 | CA2398695A1 Chondromodulin-i related peptide |
| 07/26/2001 | CA2398343A1 Virus strains for the oncolytic treatment of cancer |
| 07/26/2001 | CA2398256A1 Methods for detecting cancer of the central nervous system |
| 07/26/2001 | CA2398083A1 Nphs2 gene involved in the cortico-resistant neprhotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses |
| 07/26/2001 | CA2397919A1 Pharmaceutical compositions and methods of treatment based on vegf antisense oligonucleotides |
| 07/26/2001 | CA2397910A1 Cancer associated genes and their products |
| 07/26/2001 | CA2397903A1 Use of paramyxovirus vector for gene transfer into blood vessel |
| 07/26/2001 | CA2397783A1 Human gaba receptor proteins and polynucleotides encoding the same |
| 07/26/2001 | CA2397571A1 Apoptin-associating protein |
| 07/26/2001 | CA2397492A1 Method for nucleic acid transfection of cells |
| 07/26/2001 | CA2397324A1 Genes encoding abc1 paralogs and the polypeptides derived therefrom |
| 07/26/2001 | CA2397205A1 Antisense modulation of macrophage migration inhibitory factor expression |
| 07/26/2001 | CA2396697A1 Antisense modulation of glycogen synthase kinase 3 beta expression |
| 07/26/2001 | CA2396283A1 Human cystine knot polypeptide |
| 07/26/2001 | CA2395855A1 Recombinant flaviviruses and methods of use thereof |
| 07/26/2001 | CA2395054A1 Human polynucleotides, polypeptides, and antibodies |
| 07/26/2001 | CA2365610A1 Compositions and methods for the treatment of tumor |
| 07/25/2001 | EP1118670A1 Canine adenovirus vectors for the transfer of genes in targeted cells |
| 07/25/2001 | EP1118663A1 Nucleic acids encoding chemotaxis inhibitory polypeptides |
| 07/25/2001 | EP1118659A1 Expression systems for functional nucleic acid expression |
| 07/25/2001 | EP1117836A2 Expressionanalysis of specific nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 07/25/2001 | EP1117796A2 Calcium channel alpha-2/delta gene |
| 07/25/2001 | EP1117793A2 Secretory protein - zsig48 |
| 07/25/2001 | EP1117791A2 Cancer associated antigens and uses therefor |
| 07/25/2001 | EP1117786A2 Tmof receptor and uses thereof |
| 07/25/2001 | EP1117785A1 Human kinesin-like motor protein |
| 07/25/2001 | EP1117784A2 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity |
| 07/25/2001 | EP1117782A2 Ion channels, in particular vanilloid receptor-like (vr-l) receptor |
| 07/25/2001 | EP1117779A1 $i(MORAXELLA CATARRHALIS) PROTEIN, NUCLEIC ACID SEQUENCE AND USES THEREOF |
| 07/25/2001 | EP1117776A1 ENZYMATIC SYNTHESIS OF ssDNA |
| 07/25/2001 | EP1117775A2 Tissue binding peptides, identification, production and utilization thereof |
| 07/25/2001 | EP1117772A1 Polypeptides and polynucleotides from coagulase-negative staphylococci |
| 07/25/2001 | EP1117769A1 Cloning and recombinant production of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
| 07/25/2001 | EP1117767A1 Immunomodulation by genetic modification of dendritic cells and b-cells |
| 07/25/2001 | EP1117765A2 Stem cells bearing an fgf receptor on the cell surface |
| 07/25/2001 | EP1117762A1 Methods of controlling proliferation and differentiation of stem and progenitor cells |
| 07/25/2001 | EP1117720A1 Polyester analogue of poly-l-lysine as a soluble, biodegradable gene delivery carrier |
| 07/25/2001 | EP1117687A2 Compositions and methods for wt1 specific immunotherapy |
| 07/25/2001 | EP1117685A1 Treatment of inflammatory disease |
| 07/25/2001 | EP1117675A1 Cadherin-like asymmetry protein-1, and methods for its use |
| 07/25/2001 | EP1117672A1 Antisense modulation of survivin expression |
| 07/25/2001 | EP1117438A1 Tie2 antagonist antibodies |
| 07/25/2001 | EP1117436A1 Neisseria spp polypeptide, nucleic acid sequence and uses thereof |
| 07/25/2001 | EP1117435A1 Mutant cholera holotoxin as an adjuvant |
| 07/25/2001 | EP1117430A1 Genes differentially expressed in cancer cells to design cancer vaccines |
| 07/25/2001 | EP1117428A2 Compositions and methods for inhibiting angiogenesis |
| 07/25/2001 | EP1117378A2 Compositions and methods for enhancing receptor-mediated cellular internalization |
| 07/25/2001 | CN1305495A Peptide |
| 07/25/2001 | CN1305384A Immunomodulatory compositions of MMTV antigens and method of using same |
| 07/25/2001 | CN1305007A Pistal-type gas gene gun |
| 07/24/2001 | US6265564 Expressed ligand-vascular intercellular signalling molecule |
| 07/24/2001 | US6265563 Nucleotide sequences probes for use as diagnostic tools and drug screening |
| 07/24/2001 | US6265562 Nucleotide sequences coding transcription factor; for the treatment and prevention of infection, tumors, leukemias, autoimmune disease, allergies, arthritis, inflammation, organ rejection, graft versus host disease and coagulation defects |
| 07/24/2001 | US6265560 Nucleotide sequences coding enzymatic polypeptide associated with signal transducton; for diagnosis, prevention, and treatment of inflammation, arthritis and physiological defects |
| 07/24/2001 | US6265559 Peptide nucleic acid synthons which have protecting groups which are orthogonal; allows removal of protecting groups under mild conditions; for pna-dna chimeras |
| 07/24/2001 | US6265558 Compound of linked nucleosides having thiol group attatched at 5-pyrimidine or 2-, 6-, or 8-purine positions; attachment reporter molecules, reporter enzymes, steroids, lipophilic molecules, peptides, proteins and other groups |
| 07/24/2001 | US6265556 Nucleotide sequences coding mammalian polypeptide associated with immune response and cell propagation; for the detection of modulators of apoptosis |
| 07/24/2001 | US6265547 Polypeptide for use in diagnosis, treatment, and prevention of cancer, nervous system disorders |
| 07/24/2001 | US6265544 Adipocyte-specific protein homologs |
| 07/24/2001 | US6265543 Polypeptide for the treatment of eye disorders, tumors, cancer, psoriasis, trauma, psychological, burns and ulcers |
| 07/24/2001 | US6265390 Methods for expressing nucleic acid sequences using nucleic acid constructs comprising hypoxia response elements |
| 07/24/2001 | US6265387 Process of delivering naked DNA into a hepatocyte via bile duct |
| 07/24/2001 | US6265218 Introducing promoter and heterologous dna encoding a product into plasmid containing antibiotic resistance selection marker, amplifying, using restriction enzymes to form two fragments, cyclizing to form separate plasmids |
| 07/24/2001 | US6265216 Antisense modulation of cot oncogene expression |
| 07/24/2001 | US6265212 Making replication-defective adenovirus by transfecting cell having functional e1a and e1b but not pix proteins with nucleic acid having encapsidating signal and inverted terminal repeats, culturing cell and harvesting adenovirus |
| 07/24/2001 | US6265211 About 105 kilobases; has no detectable alpha satellite dna; mitotically stable; for artificial chromosomes; transgenic plants and animals |
| 07/24/2001 | US6265189 Expressing polypeptide in cell culture; insert gene into viral expression vector, transform cells, recover preferential polypeptide |
| 07/24/2001 | US6265188 Nucleotide sequence coding a enzymatic polypeptide; for use as a wound healing agent; for prevention of bacterial infection |
| 07/24/2001 | US6265175 Incubating components comprising neuroblast and composition to be tested for ability to stimulate or inhibit proliferation or differentiation of the neuroblast to allow composition to bind to neuroblast, culturing, detecting effect |
| 07/24/2001 | US6265173 Methods of modulating the expression of genes using ultraspiracle receptor |
| 07/24/2001 | US6265172 Detecting mutations in regulatory sequences of enzymatic polypeptides; obtain nucleotide sequences, incubate with restriction enzymes, monitor pattern, detect restriction fragment length polymorphisms |
| 07/24/2001 | US6264990 Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity. |
| 07/24/2001 | US6264955 Ferrichrome transport ATP-binding protein |
| 07/24/2001 | US6264943 Parkinson's disease |
| 07/24/2001 | US6264941 Compositions for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules |
| 07/24/2001 | US6264940 Antitumor, anticancer agent |
| 07/19/2001 | WO2001051645A1 Obg3 globular head and uses thereof for decreasing body mass |
| 07/19/2001 | WO2001051640A2 Regulation of human mitochondrial transformylase |
| 07/19/2001 | WO2001051638A2 Drug metabolizing enzymes |
| 07/19/2001 | WO2001051635A2 Novel stra6 polypeptides |
| 07/19/2001 | WO2001051631A2 Regulatory sequence for the specific expression in dendritic cells and uses thereof |
| 07/19/2001 | WO2001051626A2 Novel plasmid expression vectors |
| 07/19/2001 | WO2001051619A2 Genetically modified fibroblast cell |
| 07/19/2001 | WO2001051606A2 Cell line for preparing and producing ovine adenovirus vectors |
| 07/19/2001 | WO2001051515A2 Genes differentially expressed in breast cancer |
| 07/19/2001 | WO2001051512A2 Human and parasite orphan receptor proteins |
| 07/19/2001 | WO2001051503A1 Polynucleotides for inhibiting metastasis and tumor cell growth |
| 07/19/2001 | WO2001051093A2 METHODS OF INCREASING THE GLUCOSE RESPONSIVENESS OF PANCREATIC β-CELLS |
| 07/19/2001 | WO2001051083A2 Innate immunity-stimulating compositions of cpg and saponin and methods thereof |
| 07/19/2001 | WO2001051075A1 Enhancing lymph channel development and treatment of lymphatic obstructive disease |
| 07/19/2001 | WO2001051006A2 Cardiac-cell specific enhancer elements and uses thereof |
| 07/19/2001 | WO2001050848A2 Clonal propagation of primate offspring by embryo splitting |
| 07/19/2001 | WO2001014414A3 Human abc2 transporter and uses thereof |
| 07/19/2001 | WO2001005943A3 Lcat recombinant cell line compositions and methods |
| 07/19/2001 | WO2001005821A3 Viral il-10 for the inhibition of angiogenesis, tumorigenesis and metastasis |
| 07/19/2001 | WO2001005820A3 Method for down-regulating gdf-8 activity |
| 07/19/2001 | WO2001004297A3 Human proteins having hydrophobic domains and dnas encoding these proteins |